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What are the new findings?
 ► Myocardial changes induced by long-term endur-
ance exercise do not result in pathological hypertro-
phy or myocardial fibrosis.
How might it impact on clinical practice in the near 
future?
 ► These findings allow a better knowledge of athlete’s 
heart in veteran endurance athletes. Cardiovascular 
magnetic resonance results show that structural 
changes observed in these population correspond to 
a physiological adaptative phenomenon.
AbsTrACT
There is still some controversy about the benignity of 
structural changes observed in athlete’s heart, especially 
regarding the observation of increased biomarkers and the 
presence of myocardial fibrosis (MF).
Aim Our purpose was to evaluate by cardiovascular 
magnetic resonance (CMR) the presence of diffuse as 
well as focal MF in a series of high-performance veteran 
endurance athletes.
Methods Thirty-four veteran healthy male endurance 
athletes, still being in regular training, with more than 10 
years of training underwent a CMR. A cardiopulmonary 
exercise test was also performed to assess their maximal 
physical performance. The control group consisted in 12 
non-trained normal individuals.
results We found an increase in both, right and left 
ventricular (LV) volumes in the athlete’s group when 
compared with controls. There was no increase in indexed 
LV myocardial mass despite of a significantly increased 
maximal myocardial wall thickness in comparison to 
controls. Native T1 values and extracellular volume (ECV) 
were normal in all cases. We did not find differences 
in native T1 values and ECV between both groups. In 
three athletes (9%), non-ischaemic late gadolinium 
enhancement (LGE) was observed. We did not find a 
correlation between total training volume and presence of 
LGE or with the ECV value.
Conclusions Our results show that the majority of 
veteran endurance athletes present with myocardial 
remodelling without MF as a physiological adaptive 
phenomenon. In the only three athletes with focal MF, the 
LGE pattern observed suggests an intercurrent event not 
related with the remodelling phenomenon.
InTroduCTIon
Structural changes observed in athlete's 
heart such as increased left ventricular (LV) 
volume, increased LV wall thickness and mass 
have been generally considered as benign 
consequences of long-term physical training. 
However, several studies have demonstrated 
that acute high-intensity endurance exercise 
such as marathon or ultramarathon courses 
is associated with transient decrease in right 
ventricular systolic function.1–3 Increases in 
cardiac biomarkers of myocardial injury, such 
as troponine, have been reported to occur 
immediately after performing these activi-
ties.4 5 Recently, it has been described in an 
experimental study an association between 
long-term vigorous endurance exercise, 
arrhythmias and myocardial fibrosis (MF).6
Cardiac magnetic resonance (CMR) 
imaging allows the detection of replacement 
MF by means of the technique of late gado-
linium enhancement (LGE).  More recently, 
the estimation of the longitudinal magnetic 
relaxation time T1 of the myocardial tissue, 
from which a calculation of the myocardial 
extracellular volume (ECV) may be derived, 
this being a reliable measure of diffuse inter-
stitial fibrosis.
Although some CMR studies have already 
shown the presence of focal MF in athletes,7 8 
it is not known at present whether high-inten-
sity endurance exercise might result in diffuse 
MF.
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Our purpose was to evaluate by CMR the presence of 
diffuse as well as focal MF in a series of high-performance 
veteran endurance athletes.
MeTHods
study population
Thirty-four veteran healthy male (age 48.17±7.48 years) 
endurance athletes (runners), still being in regular 
training, with more than 10 years of training and with 
marathon times below 3 hours and 15 min, were invited 
to undergo a CMR. A cardiopulmonary exercise test was 
also performed in all individuals to assess their maximal 
physical performance. The control group consisted of 12 
untrained healthy males pair-matched for age and body 
surface area. Exclusion criteria included any history of 
cardiopulmonary disease and standard contraindications 
for CMR imaging.
The study was conducted in accordance with the stan-
dards set by the ‘Declaration of Helsinki’ and approved 
by the ethics committee of our Institution.
Cardiovascular magnetic resonance
All CMR studies were performed with a 1.5 T magnet 
(Avanto Fit, Siemens; Erlangen, Germany). LV and RV 
mass and volumes were obtained from steady-state free 
precession cine imaging covering the entire LV in the 
short-axis: retrospective ECG-gated SSFP cine sequence 
(TR=74 ms, TE=1.26 ms, slice thickness=8 mm, no gap, 
voxel size 1.3×1.3×8 mm). Cine images were analysed by 
means of dedicated software (QMass 7.1 Medis, Leiden, 
The Netherlands).
Mid LV short-axis native (precontrast) T1 maps were 
obtained using a previously described MOLLI sequence.9
A single bolus of 0.2 mmol/kg of gadobutrol (Gado-
vist , Bayer Lab. Barcelona, Spain) was administered. A 
3-dimensional inversion recovery segmented gradient 
echo sequence (spatial resolution 1.3×1.3×8 mm) was 
acquired 8–10 min after contrast administration to 
assess LGE. This sequence was used in multiple short-
axis planes using the same orientation as the cine MR 
images.
Post-contrast T1 maps were acquired using the same 
MOLLI scheme 15 min after contrast administration.
Focal MF was considered to be present when an 
intramyocardial region with hyperintense signal (>5 
SD values of the signal intensity at a remote area) was 
detected in the LGE images.
Diffuse MF was assessed using T1 mapping sequences 
by means of calculation of the ECV according to the 
equation: ECV = ∆1/T1
myocardium
 / ∆1/T1
blood
 (1-haemato-
crit).10 Haematocrit was obtained at the moment of the 
CMR study.
Cardiopulmonary exercise test
Exercise test with gas consumption was performed 
in all athletes on an Ergo-Run premium 8 ergometer 
(Daum-electronic, Fürth, Germany) using a previously 
validated11 progressive protocol. After a warm-up of 3 
min at 6 km/hour with a fixed ramp of 3%, the velocity 
was increased 1 km/hour every minute until exhaustion. 
A simultaneous breath by breath gas exchange device 
(Power-Cube, Ganshorn, Neuenkirchen, Germany) 
was used to measure: oxygen consumption (VO
2
) (in 
L/min and ml/kg/min); carbon dioxide production 
(VCO
2
) (in L/min); respiratory quotient (RER); anaer-
obic threshold (UAn) based on heart rate, percentage 
of VO
2
 achieved at the UAn (%VO
2
) and ventilation/ 
minute (VE) (in L/min). Signals from a 12 lead ECG 
were displayed continuously using a Cardiovit AT-104 
system (Schiller España, Madrid, Spain). Blood pres-
sure was measured at 3 min intervals during exercise 
and for the first 3 min after exercise, using a manual 
sphygmomanometer. Criteria for termination of exer-
cise test were to yield physical exhaustion or a plateau 
in VO
2
. Maximal cardiopulmonary exercise test was 
defined by a plateau in VO
2
 and/or achievement of a 
peak RER of ≥1.10
statistical analysis
Continuous variables are presented as mean±SD when 
normally distributed and median±IQR when not. 
Normal distribution of data was assessed by using Shap-
piro-Wilk test.
To analyse the differences between pairwise matched 
athletes and control subjects a Student’s t-test was used. 
Wilcoxon signed-rank test was performed for non-nor-
mally distributed variables. A multivariate-logistic 
regression model was used to control for confounding 
baseline variables. All p<0.05, 2-tailed approach, and 
power of 80% were used in all tests.
resulTs
Patient demographics and functional measures are 
summarised in table 1. VO
2
 values shown in the athlete’s 
group were in the range of well highly trained subjects 
according to reference values.11
CMR results are shown in table 2. We found an increase 
in both right and LV volumes in the athlete’s group when 
compared with controls. Left and right ejection fractions 
were preserved in all patients. There was no increase in 
indexed LV myocardial mass despite of a significantly 
increased maximal myocardial wall thickness in compar-
ison to controls.
Native T1 values and ECV were normal in all cases. 
We found significant differences between athletes 
and control subjects in the univariate analysis. When 
corrected by the haematocrit in the multivariate analysis, 
we did not find differences in native T1 values and ECV 
between both groups (table 2).
In three athletes (9%) ,non-ischaemic LGE pattern was 
noted: mesocardial in septal-apical wall, subepicardial in 
the inferior apical wall and mesocardial in the lateral wall 
(figure 1).
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Table 1 Demographic and functional characteristics of endurance athletes and control subjects
Athletes (n= 34) Controls (n= 12) P values
Age (years) 48.18±7.48 42.36±13.43 n.s
BSA (m2) 1.80±0.11 1.89±0.14 n.s
Training volume (hours/week) 9.38±3.52 3.08±1.52 <0.05
Training history (years) 28.06±10.84 9.38±3.02 <0.05
Rest heart rate (bpm) 56.03±8.87 70.33±15.42 <0.05
VO
2
 peak (mL/min/kg) 60±6.53
Peak heart rate (bpm) 176.27±10.32
RER max 1.14±0.07
Data are presented as mean value±SD. VO
2
 peak, maximal oxygen uptake.
BSA, body surface area; RER max, maximal respiratory exchange ratio.
Table 2 CMR results
Athletes (mean±SD) Controls (mean±SD) P values
LVEDV (mL) 193.65±31.67 155.92±26.30 <0.001
LVEDV index (mL/m2) 107.53±15.94 81.33±10.71 <0.001
LVESV (mL) 72.47±15.98 57.75±13.96 <0.001
LVESV index (mL/m2) 40.29±8.59 30.08±6.32 <0.001
LVEF (%) 62.53±4.89 63±5.15 0.779
RVEDV (mL) 204.44±37.50 165.58±31.90 0.003
RVEDV index (mL/m2) 113.59±19.83 86.42±13.57 <0.001
RVESV (mL) 76.12±20.69 64.67±17.15 0.086*
RVESV index (mL/m2) 42.38±11.61 33.83±7.85 0.023*
RVEF (%) 62.91±6.24 61.5±5.27 0.488
Ratio RV-LV 0.96±0.10 0.96±0.14 0.968
LVM (g) 124.59±22.13 124.54±32.23 0.996
LVM index (g/m2) 69±11.05 65.25±15.73 0.372
Max wall thickness (mm) 11±1.33 8.50±2.65 <0.001*
LA area (cm2) 28.03±3.71 24.67±4.16 0.013
T1 mapping 
  Native T1 septal (ms) 943.59±52.58 984.13±36.82 0.006* NS
  Native T1Lat (ms) 925.3±45.90 960.25±29.77 0.029* NS
  ECV septal 0.25±0.02 0.22±0.02 <0.001 NS
  ECVLat 0.24±0.04 0.17±0.08 0.006 NS
  Haematocrit (%) 0.42±0.02 0.46±0.04 0.001* S
  DE* 3(9%) 0
CMR, cardiovascular magnetic resonance; DE, delayed-enhancement; ECV, extracellular volume; LA, left atrial; LVEDV, left ventricular 
end-diastolic volume; LVEF, left ventricular ejection fraction; LVM, left ventricular mass; RVEDV, right ventricular end-diastolic volume; 
RVEF, right ventricular ejection fraction.
We did not find a correlation between total training 
volume and presence of LGE nor with the ECV value.
dIsCussIon
In this study, we have examined a cohort of veteran 
endurance athletes and a paired untrained control 
group to evaluate the consequences of long time 
practice of intense endurance exercise on myocardial 
structure to find that:
1. Cardiac remodelling in endurance athletes is charac-
terised by a balanced increase in left and right ven-
tricular volumes and in maximal LV wall thickness, 
despite of normal indexed myocardial mass.
2. This remodelling process does not involve an expan-
sion of the interstitial space by MF, as proven by the 
normal values of the ECV, suggesting a physiological 
adaptive phenomenon in these highly trained individ-
uals.
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Figure 1 LGE images of the three athletes showing MF. (A) A 55-year-old athlete who has been training 10 hours/week in the 
last 28 years. Mesocardial LGE in the apical-septal wall is shown in a 3-chamber view image. (B) A 51-year-old athlete training 
7 hours/week in the last 30 years. The short-axis view shows subepicardial LGE in the inferior apical wall. (C) A 55-year-old 
athlete training 8 hours/week in the last 30 years. Mild intramyocardial LGE is the lateral wall is shown in the 4-chamber view. 
LGE, late gadolinium enhancement; MF, myocardial fibrosis.
3. In 9% of athletes, however, focal MF was observed, 
which could be due to an intercurrent phenomenon 
of uncertain origin.
Morphological and functional parameters
Cardiac adaptation in veteran, high-performance endur-
ance athletes is characterised by balanced increase of LV 
and RV volumes, increased LV wall thickness and myocar-
dial mass,12 13 leading to what is known as the athlete’s 
heart. Accordingly, our cohort showed significantly 
enlarged left and right ventricles compared to control 
subjects, with no significant differences in the LVEDV-
to-RVEDV ratio. Also, athletes showed an increase in 
absolute wall thickness compared to control subjects. 
However, in accordance with previous reports,14 values of 
indexed LV mass are within normal ranges. The present 
study also proves the preservation of LV and RV ejection 
fraction in lifelong endurance veteran athletes.
Focal myocardial fibrosis 
LGE was observed in three (9%) athletes, all of them 
showing a non-ischaemic pattern (figure 1A–C). Further-
more, in two of them, delayed-enhancement patterns 
were highly suggestive of a previous episode of clinically 
undetected myocarditis (figure 1 B,C).
There is still some controversy regarding on whether 
repeated extreme endurance exercise might result in MF. 
Benito et al6 exercised rats on a treadmill and observed 
diffuse fibrosis in the atria and right ventricle which 
resulted in ventricular arrhythmia. CMR studies have 
also reported an apparently high incidence of focal MF 
in veteran athletes: Breuckmann et al7 examined 102 
healthy veteran male marathon runners and reported an 
unexpectedly high prevalence of LGE (12%), although it 
was not significantly different from that of age-matched 
control participants (4%, p=0.07). Another study15 found 
focal MF by LGE in 6 of 12 elite veteran athletes but not 
in 20 age-matched controls or in 17 young endurance 
athletes. The presence of LGE in veteran athletes was 
significantly associated with the training volume, 
supporting a link between life-long endurance exercise 
and MF.
More recently, La Gerche et al16 showed LGE in 5 of 40 
(13%) athletes studied which was confined to the inter-
ventricular septum in all cases.
In two of the three athletes, we found a LGE pattern 
highly suggestive of a previous myocarditis as the potential 
cause. It would be reasonable to believe that continued 
exercise training may accelerate myocardial damage and 
MF during silent myocarditis.17
MF in the RV insertion point has been reported in up to 
19% of athletes in the literature,18 and it is an important 
topic of debate. It is speculated that the RV distention 
during exercise may result in chronic structural changes 
of the myocardial architecture, mainly in the septal 
points of insertion of the right ventricular wall. In our 
study, we found mild LGE in the inferior septal RV inser-
tion in 23% of athletes. However, we did not consider this 
finding as true reactive MF. In fact, this finding was also 
observed in 36% of controls (figure 2). We believe that, 
as previously reported,17 19 plexiform fibrosis is a normal 
feature of the insertion-region anatomy that may result in 
contrast pooling within this area.
dIFFuse MyoCArdIAl FIbrosIs
Importantly, we did not find significant differences in 
ECV in athletes compared with control group. Extra-
cellular expansion leads to higher ECV measurements. 
Thus, our findings support that cardiac remodelling in 
veteran athletes is a physiological adaptive phenomenon.
Previously, McDiarmid et al20 showed in young athletes 
that the increase in LV mass is due to increased cellular 
mass which, in turn, results in a relative decrease in ECV 
compared with controls. These findings also support the 
hypothesis of a physiological adaptation instead of patho-
logical hypertrophy with associated interstitial fibrosis.21 
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Figure 2 A 40-year-old man with a training history of 2 
hours/week during 6 years (Control group). A mid-ventricular 
short-axis view shows mild LGE in the inferior RV-LV 
junction.
However, in the present study, we did not find significant 
differences in ECV between athletes and controls. This 
discrepancy may be explained by differences in athlete 
population between McDiarmid’s study and ours. Our 
study comprised veteran endurance athletes (mean age: 
47.18±7.48), much older than the study subjects from 
their study (31.7±7.7 years), and our results are according 
to a previous study by Mordi et al22 also with veteran 
endurance athletes in which they did not find a decrease 
in ECV in athletes compared with sedentary controls. 
More studies will be required to confirm whether there 
are significant differences in ECV between young and 
veteran athletes.
In our population of veteran runners with more than 
10 years of intense training, we did not find a correla-
tion between total training volume and MF of any kind 
and neither between ECV and maximal wall thickness 
nor LV mass. Thus, according to our results, running 
at high doses and intensities does not seem to result in 
developing interstitial fibrosis. However, more studies are 
needed including young and veteran athletes and from 
different sports.
lIMITATIons
Only 46 subjects were enrolled in this study, which may be 
a limitation when comparing structural cardiac changes 
between the two groups, particularly when assessing 
myocardial LGE patterns.
A cardiopulmonary exercise test to the control group 
was not performed, as the only purpose of this test was 
to show the excellent athletic performance of the study 
group. The present study is only referred to Caucasian 
male veteran athletes as we did not study black, young or 
female athletes.
ConClusIon
Our results show that the majority of veteran endurance 
athletes present with myocardial remodelling without MF 
as a physiological adaptive phenomenon. Furthermore, 
in the only three athletes with focal MF, the LGE pattern 
observed suggests an intercurrent event not related with 
their modelling phenomenon.
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